The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases
Open accessAbstract
Inflammation and lipid accumulation are two basic hallmarks of atherosclerosis as a chronic disease. Inflammation not only is a local response but can also be considered as a systemic process followed by an elevation of inflammatory mediators. Monocytes are a major source of proinflammatory species during atherogenesis. In atherosclerosis, modified low‐density lipoproteins (LDLs) are removed by macrophages; these are recruited in the vessel wall, inducing the release of inflammatory cytokines in inflamed tissue. Hence, inflammatory cholesterol ester‐loaded plaque is generated. High‐density lipoprotein‐cholesterol (HDL‐C) exhibits antiatherosclerotic effects by neutralizing the proinflammatory and pro‐oxidant effects of monocytes via inhibiting the migration of macrophages and LDL oxidation in addition to the efflux of cholesterol from these cells. Furthermore, HDL plays a role in suppressing the activation of monocytes and proliferation–differentiation of monocyte progenitor cells. Thus, accumulation of monocytes and reduction of HDL‐C may participate in atherosclerosis and cardiovascular diseases (CVD). Given that the relationship between the high number of monocytes and low HDL‐C levels has been reported in inflammatory disorders, this review focused on understanding whether the monocyte‐to‐HDL ratio could be a convenient marker to predict atherosclerosis development and progression, hallmarks of CV events, instead of the individual monocyte count or HDL‐C level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Inflammation and cardiovascular disease mechanisms
Libby, P. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.456s · Cited by 1,104
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
Yvan-Charvet, L., Pagler, T., Gautier, E. L., Avagyan, S., Siry, R. L., Han, S., Welch, C. L., Wang, N., Randolph, G. J., Snoeck, H. W., et al. (2010) · Science · doi:10.1126/science.1189731 · Cited by 725
Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
Cachofeiro, V., Goicochea, M., de Vinuesa, S. G., Oubiña, P., Lahera, V., & Luño, J. (2008) · Kidney International · doi:10.1038/ki.2008.516 · Cited by 662
High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., & Chin-Dusting, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168690 · Cited by 508
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281
Self-citationStructure of HDL: Particle Subclasses and Molecular Components
Kontush, A., Lindahl, M., Lhomme, M., Calabresi, L., Chapman, M. J., & Davidson, W. S. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0_1 · Cited by 281
Kanbay, M., Solak, Y., Unal, H. U., Kurt, Y. G., Gok, M., Cetinkaya, H., Karaman, M., Oguz, Y., Eyileten, T., Vural, A., et al. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0730-1 · Cited by 276
Novel biomarkers for cardiovascular risk prediction.
Wang, J., Tan, G.-J., Han, L.-N., Bai, Y., He, M., & Liu, H. (2017) · PubMed · doi:10.11909/j.issn.1671-5411.2017.02.008 · Cited by 256
Deedwania, P. C. (2004) · Circulation · doi:10.1161/01.cir.0000110642.73995.bf · Cited by 236
Canpolat, U., Çetin, E. H., Cetin, S., Aydin, S., Akboga, M. K., Yayla, C., Turak, O., Aras, D., & Aydogdu, S. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615594002 · Cited by 213
Cetin, M. S., Ozcan Cetin, E. H., Kalender, E., Aydin, S., Topaloglu, S., Kisacik, H. L., & Temizhan, A. (2016) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2016.02.023 · Cited by 194
Sahebkar, A., Chew, G. T., & Watts, G. F. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.876992 · Cited by 180
Self-citationSahebkar, A., & Watts, G. F. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.06.019 · Cited by 180
Self-citationSahebkar, A., & Watts, G. F. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6479-4 · Cited by 175
Self-citationChemokines and Cardiovascular Risk
Aukrust, P., Halvorsen, B., Yndestad, A., Ueland, T., Øie, E., Otterdal, K., Gullestad, L., & Damås, J. K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161240 · Cited by 174
Markers of inflammation and their clinical significance
Ballantyne, C. M., & Nambi, V. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.005 · Cited by 164
Lipid-modifying effects of nutraceuticals: An evidence-based approach
Sahebkar, A., Serban, M.-C., Gluba-Brzózka, A., Mikhailidis, D. P., Cicero, A. F., Rysz, J., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.007 · Cited by 157
Self-citationMonocytes as a diagnostic marker of cardiovascular diseases
Gratchev, A. N., Sobenin, I. A., Orekhov, A. N., & Kzhyshkowska, J. G. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.01.008 · Cited by 153
Canpolat, U., Aytemir, K., Yorgun, H., ŞAHINER, L., Kaya, E. B., Çay, S., Topaloğlu, S., Aras, D., & Oto, A. (2015) · EP Europace · doi:10.1093/europace/euu291 · Cited by 139
Acute kidney injury in patients with acute coronary syndromes
Marenzi, G., Cosentino, N., & Bartorelli, A. L. (2015) · Heart · doi:10.1136/heartjnl-2015-307773 · Cited by 117
Turhan, H., Erbay, A. R., Yaşar, A. S., Balcı, M. M., Biçer, A., & Yetkın, E. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.120 · Cited by 113
Kundi, H., Kızıltunç, E., Cetin, M., Cicekcioglu, H., Çetin, Z. G., Çiçek, G., & Örnek, E. (2016) · Herz · doi:10.1007/s00059-015-4393-1 · Cited by 108
A past and present overview of macrophage metabolism and functional outcomes
Curi, R., Mendes, R. D. S., Crispin, L. A. D. C., Norata, G. D., Sampaio, S. C., & Newsholme, P. (2017) · Clinical Science · doi:10.1042/cs20170220 · Cited by 107
Akboğa, M. K., Balcı, K. G., Maden, O., Ertem, A. G., Kırbaş, Ö., Yayla, Ç., Açar, B., Aras, D., Kisacik, H. L., & Aydoğdu, S. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2015-0050 · Cited by 102
Rogacev, K. S., Zawada, A. M., Emrich, I. E., Seiler, S., Böhm, M., Fliser, D., Woollard, K. J., & Heine, G. H. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304172 · Cited by 101
Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients
Bolayir, A., Gokce, S. F., Cigdem, B., Bolayir, H. A., Yildiz, O. K., Bolayir, E., & Topaktas, S. A. (2018) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2017.08.011 · Cited by 98
Karataş, M. B., Çanga, Y., Özcan, K. S., İpek, G., Güngör, B., Onuk, T., Durmuş, G., Öz, A., Karaca, M., & Bolca, O. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.10.049 · Cited by 97
Cetin, E. H. O., Cetin, M. S., Canpolat, U., Aydin, S., Topaloglu, S., Aras, D., & Aydogdu, S. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.74 · Cited by 90 · cited 2×
“…inflammation, with serum CRP levels as a marker, and MHR was also confirmed in patients with STEMI treated with primary PCI (r = 0.442; E. H. O. Cetin et al., 2015), in those with slow coronary flow (r = 0.352; Canpolat et al., 2014) and acute coronary syndromes (r = 0.394; M. S. Cetin et al.,…”
BackgroundInfluentialUsta, A., Avcı, E., Bülbül, Ç. B., Kadı, H., & Adalı, E. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0351-0 · Cited by 83
Vahit, D., Akboga, M. K., Samet, Y., & Hüseyin, E. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0380 · Cited by 82
Kundi, H., Gök, M., Kızıltunç, E., Çetın, M., Çiçekçioğlu, H., Çetin, Z. G., Karayiğit, O., & Örnek, E. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.08.036 · Cited by 82
Açıkgöz, N., Kurtoğlu, E., Yağmur, J., Kapıcıoğlu, Y., Cansel, M., & Ermiş, N. (2017) · Angiology · doi:10.1177/0003319717704748 · Cited by 76
Zhang, Y., Li, S., Guo, Y., Wu, N., Zhu, C., Gao, Y., Xu, R., Dong, Q., Liu, G., Sun, J., et al. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1168935 · Cited by 74
You, S., Zhong, C., Zheng, D., Xu, J., Zhang, X., Liu, H., Zhang, Y., Shi, J., Huang, Z., Cao, Y., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.022 · Cited by 70
HDL abnormalities in familial hypercholesterolemia: Focus on biological functions
Ganjali, S., Momtazi‐Borojeni, A. A., Banach, M., Kovanen, P. T., Stein, E. A., & Sahebkar, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.05.001 · Cited by 69
Self-citationA potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio
Uçar, F. M. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0367-3 · Cited by 68
Ruscica, M., Baragetti, A., Catapano, A. L., & Norata, G. D. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.12.005 · Cited by 68
Self-citationGomaraschi, M., Basilico, N., Sisto, F., Taramelli, D., Eligini, S., Colli, S., Sirtori, C. R., Franceschini, G., & Calabresi, L. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.003 · Cited by 67
Uslu, A. U., Sekin, Y., Tarhan, G., Canakcı, N., Gündüz, M., & Karagülle, M. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617741362 · Cited by 63
Çiçek, G., Kundi, H., Bozbay, M., Yayla, Ç., & Uyarel, H. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000343 · Cited by 59
Balta, Ş., Celık, T., Öztürk, C., Kaya, M. G., Aparcı, M., Yıldırım, A. O., Demır, M., Kılıç, S., Aydın, İ., & Iyısoy, A. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.05.031 · Cited by 59
Köseoğlu, H. İ., Pazarlı, A. C., Kanbay, A., & Demir, O. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616677803 · Cited by 59
Aydin, E., Ateş, İ., Arikan, M. F., Yılmaz, N., & Dede, F. (2017) · Hypertension Research · doi:10.1038/hr.2017.36 · Cited by 54
Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
Krychtiuk, K. A., Kastl, S., Pfaffenberger, S., Pongratz, T., Hofbauer, S. L., Wonnerth, A., Katsaros, K. M., Goliasch, G., Gašpar, Ľ., Huber, K., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.015 · Cited by 48
Yilmaz, S., Akboğa, M. K., Sen, F., Balcı, K. G., Aras, D., Temizhan, A., & Aydoğdu, S. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0069 · Cited by 47
Suzuki, A., Fukuzawa, K., Yamashita, T., Yoshida, A., Sasaki, N., Emoto, T., Takei, A., Fujiwara, R., Nakanishi, T., Yamashita, S., et al. (2016) · EP Europace · doi:10.1093/europace/euv422 · Cited by 46
Tani, S., Matsumoto, M., Anazawa, T., Kawamata, H., Furuya, S., Takahashi, H., Iida, K., Washio, T., Kumabe, N., Kobori, M., et al. (2011) · Heart and Vessels · doi:10.1007/s00380-011-0130-8 · Cited by 41
Ammirati, E., Moroni, F., Magnoni, M., Terlizzi, S. D., Villa, C., Sizzano, F., Palini, A. G., Garlaschelli, K., Tripiciano, F., Scotti, I., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.004 · Cited by 39
Sağ, S., Yıldız, A., Kaderlï, A. A., Gul, C. B., Bedir, Ö., Çeğilli, E., Özdemir, B. H., Can, F. E., & Aydınlar, A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0005 · Cited by 35
Wei, X., Chen, F., Huang, J.-L., He, P., Wei, Y., Tan, N., Chen, J.-Y., Yu, D., & Liu, Y.-H. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0427 · Cited by 35
Şaşkın, H., Özcan, K. S., & Yılmaz, S. (2016) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivw376 · Cited by 34
Yayla, Ç., Balcı, K. G., Özeke, Ö., Maden, O., Kisacik, H. L., Temizhan, A., Aydoğdu, S., & Akboğa, M. K. (2016) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0036-1582260 · Cited by 33
Increased monocyte-to-HDL cholesterol ratio is related to cardiac syndrome X
Doğan, A., & Oylumlu, M. (2017) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2017.1299521 · Cited by 31
Ossoli, A., Remaley, A. T., Vaisman, B. L., Calabresi, L., & Gomaraschi, M. (2015) · Biochemical Journal · doi:10.1042/bj20151000 · Cited by 30
Korkmaz, A., Demir, M., Unal, S., Yildiz, A., Ozyazgan, B., Demirtas, B., Elalmis, O. U., Ileri, M., & Guray, U. (2017) · International Journal of the Cardiovascular Academy · doi:10.1016/j.ijcac.2017.05.008 · Cited by 29
Yayla, K. G., Canpolat, U., Yayla, Ç., Akboğa, M. K., Akyel, A., Akdi, A., Çiçek, G., Özcan, F., Turak, O., & Aydoğdu, S. (2017) · PubMed · doi:10.6515/acs20160427a · Cited by 27
Tok, D., Turak, O., Yayla, Ç., Özcan, F., Tok, D., & Cagli, K. E. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0071 · Cited by 25
Cagli, K. E., Tok, D., Turak, O., Günertem, E., Yayla, Ç., Lafçı, G., Ulaş, M. M., & Çağlı, K. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0157 · Cited by 23
Ganjali, S., Momtazi‐Borojeni, A. A., Banach, M., Kovanen, P. T., Gotto, A. M., & Sahebkar, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.09.014 · Cited by 21
Self-citationSala, F., Cutuli, L., Grigore, L., Pirillo, A., Chiesa, G., Catapano, A. L., & Norata, G. D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.103 · Cited by 18
Yücetaş, U., Kadıhasanoğlu, M., Karabay, E., Erkan, E., & Ozbek, E. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.03.003 · Cited by 3
Cited by
Huang, J.-B., Chen, Y.-S., Ji, H.-Y., Xie, W.-M., Jiang, J., Ran, L.-S., Zhang, C.-T., & Quan, X.-Q. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01238-2 · Cited by 123
Korkmaz, Ş. A., & Kızgın, S. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2260302 · Cited by 33
Liu, H., Zhan, F., & Wang, Y. (2020) · Journal of International Medical Research · doi:10.1177/0300060520933806 · Cited by 31
Elevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression
Li, Y., Zhang, M., Xue, M., Liu, D., & Sun, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.902022 · Cited by 27
Kulacaoglu, F., Yıldırım, Y. E., Aslan, M., & İzci, F. (2023) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2022.2116106 · Cited by 18
Metadata
- Authors
- Ganjali, S., Gotto, A. M., Ruscica, M., Atkin, S. L., Butler, A. E., Banach, M., & Sahebkar, A.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-08-04
- Volume
- 233
- Issue
- 12
- Pages
- 9237-9246
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2885257262
- Cited by
- 313
- References
- 67
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.